Literature DB >> 12176505

Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection.

George W Burke1, C Ciancio, B B Blomberg, A Rosen, K Suzart, D Roth, W Kupin, V Esquenazi, J Miller.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12176505     DOI： 10.1016/s0041-1345(02)03042-7

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

Review 1.  Tacrolimus: a further update of its use in the management of organ transplantation.

Authors:  Lesley J Scott; Kate McKeage; Susan J Keam; Greg L Plosker
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.

Authors:  Deirdre Hahn; Elisabeth M Hodson; Lorraine A Hamiwka; Vincent Ws Lee; Jeremy R Chapman; Jonathan C Craig; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2019-12-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.